Triple
T31535383
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | subthalamic nucleus |
E804588
|
entity |
| Predicate | hasNeurotransmitterProfile |
P77980
|
FINISHED |
| Object | primarily glutamatergic |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: primarily glutamatergic | Statement: [subthalamic nucleus, hasNeurotransmitterProfile, primarily glutamatergic]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasNeurotransmitterProfile Context triple: [subthalamic nucleus, hasNeurotransmitterProfile, primarily glutamatergic]
-
A.
neurotransmitterSystems
Indicates the relationship between an entity and the neurotransmitter pathways or systems it involves, affects, or is associated with in neural signaling.
-
B.
neurotransmitter
chosen
Indicates that one entity functions as a chemical messenger released by a neuron to transmit signals to another cell across a synapse.
-
C.
pharmacologicalProfile
Indicates the relationship between a substance and the set of its pharmacological properties, including mechanisms of action, effects, and interactions in a biological system.
-
D.
hasBrainCharacteristic
Indicates that an entity possesses a specific feature, quality, or attribute related to the brain.
-
E.
psychoactiveProfile
Indicates the characteristic pattern of psychoactive effects or mental state changes produced by a substance, treatment, or exposure.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f348d03ef88190a2b73d7b94b9e02d |
completed | April 30, 2026, 12:19 p.m. |
| NER | Named-entity recognition | batch_69ff0214d7348190904688376df99bce |
completed | May 9, 2026, 9:44 a.m. |
| PD | Predicate disambiguation | batch_69feffd62fec8190a855922c8b3c57cf |
completed | May 9, 2026, 9:35 a.m. |
Created at: April 30, 2026, 10:03 p.m.